Reversing DOACS: Providing Answers to What, Where and How

Описание: This video is available for 1.0 AMA PRA Category 1 Credit(s)™
Click here to claim credit: https://surveys.francefoundation.com/...
Click here to view CME: https://www.francefoundation.com/9099...

In this webinar, experts discuss pharmacologic options to manage DOAC-related bleeding, specific indications, and safety and efficacy considerations.

Faculty Disclosures
The faculty listed below report that they have no relevant financial relationships to disclose:

Allison E. Burnett, PharmD, PhC, CACP
The faculty listed below report that they have relevant financial relationships to disclose:

Deborah Siegal, MD, MSc, FRCPC, has received speaker fees from Aspen Pharma, BMS‐Pfizer, Leo Pharma, Novartis, Portola, and Servier
Geoff Barnes, MD, MSc, is a consultant for Pfizer/Bristol Myers Squibb, Janssen, and AMAG Pharmaceuticals
F. A. (Erik) Klok, MD, PhD, has received research support by LUMC from Bayer, Actelion, The Netherlands Organization for Health Research and Development, the Dutch Thrombosis Association, and the Dutch Heart Foundation

The France Foundation resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

This information is intended for health care providers.

Supported through an educational grant from Alexion Pharmaceuticals, Inc.